Multicenter Trial For Patients With Acute Crohn's Disease

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

NCT00102921 ·Status: COMPLETED ·Phase: PHASE2

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

NCT06332534 ·Status: RECRUITING ·Phase: PHASE3

The Safety And Efficacy Of Maintenance Therapy With CP-690,550

NCT01393899 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of Entocort for Children With Crohn's Disease

NCT01444092 ·Status: COMPLETED ·Phase: PHASE3

CP-461 for the Treatment of Crohn's Disease

NCT00042055 ·Status: COMPLETED ·Phase: PHASE2

Safety and Maintenance Study of Entocort for Children With Crohn's Disease

NCT01453946 ·Status: COMPLETED ·Phase: PHASE3

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00105300 ·Status: COMPLETED ·Phase: PHASE3

A Study of Abatacept in Patients With Active Crohn's Disease

NCT00406653 ·Status: TERMINATED ·Phase: PHASE3

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

NCT04173273 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

NCT01951326 ·Status: COMPLETED ·Phase: PHASE3

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

NCT07196722 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

NCT01235689 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

NCT02065570 ·Status: COMPLETED ·Phase: PHASE3

Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease

NCT00101946 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

NCT01369329 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 ·Status: COMPLETED ·Phase: PHASE2

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

NCT07184931 ·Status: RECRUITING ·Phase: PHASE3

Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease

NCT03992469 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

NCT00409682 ·Status: COMPLETED ·Phase: PHASE3

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

NCT00562887 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease

NCT05049525 ·Status: TERMINATED ·Phase: PHASE2

Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease

NCT00280956 ·Status: COMPLETED ·Phase: PHASE4

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

NCT00055367 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

NCT02531113 ·Status: COMPLETED ·Phase: PHASE2

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

NCT00338650 ·Status: COMPLETED ·Phase: PHASE3